Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Leprostatic Agents"" wg kryterium: Temat


Tytuł:
Leprosy: treatment, prevention, immune response and gene function.
Autorzy:
Li X; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, China.
Ma Y; Chronic Infectious Disease Control Section, Nantong Center for Disease Control and Prevention, Nantong, China.
Li G; Department of Chronic Infectious Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Jin G; Department of Chronic Infectious Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Xu L; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, China.
Li Y; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, China.
Wei P; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, China.
Zhang L; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, China.; Department of Chronic Infectious Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 19; Vol. 15, pp. 1298749. Date of Electronic Publication: 2024 Feb 19 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Leprostatic Agents*/therapeutic use
Leprosy*/drug therapy
Leprosy*/genetics
Leprosy*/prevention & control
Humans ; Drug Therapy, Combination ; Rifampin ; Immunity
Czasopismo naukowe
Tytuł:
Complementary supramolecular drug associates in perfecting the multidrug therapy against multidrug resistant bacteria.
Autorzy:
Sahoo P; International Center for Materials and Nanoarchitectronics (MANA), Research Center for Advanced Measurement and Characterization (RCAMC), National Institute for Materials Science, Tsukuba, Japan.; Foundation of Physics Research Center (FoPRC), Celico, Italy.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 13; Vol. 15, pp. 1352483. Date of Electronic Publication: 2024 Feb 13 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Leprostatic Agents*
Drug Resistance, Multiple, Bacterial*
Drug Therapy, Combination ; Bacteria/metabolism ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/metabolism
Czasopismo naukowe
Tytuł:
Microarray data analysis of antileukemic action of Cinnamoylated benzaldehyde LQB-461 in Jurkat cell line.
Autorzy:
Thimoteo RRC; Departamento de Bioquímica, UERJ, Rio de Janeiro, RJ, Brazil.
Neto PN; Programa de Carcinogênese Molecular, INCA, Rio de Janeiro, RJ, Brazil.
Costa DSS; Instituto de Pesquisas Biomédicas - HNMD Marinha do Brazil, Rio de Janeiro, RJ, Brazil.
da Mota Ramalho Costa F; Laboratório de Microbiologia Celular IOC/Fiocruz, Rio de Janeiro, RJ, Brazil.
Brito DC; Departamento de Química Orgânica, UERJ, Rio de Janeiro, RJ, Brazil.
Costa PRR; Laboratório de Química Bioorgânica, UFRJ, Rio de Janeiro, RJ, Brazil.
de Almeida Simão T; Departamento de Bioquímica, UERJ, Rio de Janeiro, RJ, Brazil.
Dias AG; Departamento de Química Orgânica, UERJ, Rio de Janeiro, RJ, Brazil.
Justo G; Departamento de Bioquímica, UERJ, Rio de Janeiro, RJ, Brazil. .
Pokaż więcej
Źródło:
Molecular biology reports [Mol Biol Rep] 2024 Jan 25; Vol. 51 (1), pp. 187. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
Benzaldehydes*
Leprostatic Agents*
Imines*
Humans ; Drug Therapy, Combination ; Jurkat Cells ; Data Analysis
Czasopismo naukowe
Tytuł:
Association of PTX3 gene polymorphisms and PTX3 plasma levels with leprosy susceptibility.
Autorzy:
Moraes ACCG; Postgraduate Program in Health and Biological Sciences, Federal University of the São Francisco Valley (UNIVASF), Pernambuco, Brazil.
da Luz RCFV; Postgraduate Program in Health and Biological Sciences, Federal University of the São Francisco Valley (UNIVASF), Pernambuco, Brazil.
Fernandes ALM; Foundation of Hematology and Hemotherapy of Bahia (HEMOBA), Bahia, Brazil.
Barbosa MXS; Postgraduate Program in Biosciences, Federal University of the São Francisco Valley (UNIVASF), Pernambuco, Brazil.
de Andrade LV; Postgraduate Program in Biosciences, Federal University of the São Francisco Valley (UNIVASF), Pernambuco, Brazil.
Armstrong ADC; College of Medicine, Federal University of the São Francisco Valley (UNIVASF), Av. José de Sá Maniçoba, s/n, Centro, Petrolina, PE, Brazil.
de Souza CDF; College of Medicine, Federal University of the São Francisco Valley (UNIVASF), Av. José de Sá Maniçoba, s/n, Centro, Petrolina, PE, Brazil.
do Carmo RF; Postgraduate Program in Health and Biological Sciences, Federal University of the São Francisco Valley (UNIVASF), Pernambuco, Brazil. .; Postgraduate Program in Biosciences, Federal University of the São Francisco Valley (UNIVASF), Pernambuco, Brazil. .; College of Medicine, Federal University of the São Francisco Valley (UNIVASF), Av. José de Sá Maniçoba, s/n, Centro, Petrolina, PE, Brazil. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Dec 05; Vol. 23 (1), pp. 853. Date of Electronic Publication: 2023 Dec 05.
Typ publikacji:
Journal Article
MeSH Terms:
Leprostatic Agents*
Leprosy*/genetics
Humans ; Drug Therapy, Combination ; C-Reactive Protein/genetics ; C-Reactive Protein/analysis ; Biomarkers ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
[Leprosy epidemiology in Daoukro health district (Côte d'Ivoire) from 1999 to 2017].
Autorzy:
Tetchi EOS; Département de santé publique et spécialités, UFR Sciences médicales, Université Félix Houphouët Boigny, Abidjan, Côte d'Ivoire.; Institut national de santé publique, Abidjan, Côte d'Ivoire.
Konan YE; Département de santé publique et spécialités, UFR Sciences médicales, Université Félix Houphouët Boigny, Abidjan, Côte d'Ivoire.; Institut national de santé publique, Abidjan, Côte d'Ivoire.
Kpebo D; Département de santé publique et spécialités, UFR Sciences médicales, Université Félix Houphouët Boigny, Abidjan, Côte d'Ivoire.; Institut national de santé publique, Abidjan, Côte d'Ivoire.
Djoman MC; Département de santé publique et spécialités, UFR Sciences médicales, Université Félix Houphouët Boigny, Abidjan, Côte d'Ivoire.; Institut national d'hygiène publique, Abidjan, Côte d'Ivoire.
Ekou FK; Département de santé publique et spécialités, UFR Sciences médicales, Université Félix Houphouët Boigny, Abidjan, Côte d'Ivoire.; Institut national de santé publique, Abidjan, Côte d'Ivoire.
Sable PS; Département de santé publique et spécialités, UFR Sciences médicales, Université Félix Houphouët Boigny, Abidjan, Côte d'Ivoire.; Institut national de santé publique, Abidjan, Côte d'Ivoire.
Yapi A; Institut national de santé publique, Abidjan, Côte d'Ivoire.
Tano-Ake O; Département de santé publique et spécialités, UFR Sciences médicales, Université Félix Houphouët Boigny, Abidjan, Côte d'Ivoire.; Institut national de santé publique, Abidjan, Côte d'Ivoire.
Pokaż więcej
Transliterated Title:
Épidémiologie de la lèpre dans le district sanitaire de Daoukro (Côte d'Ivoire) de 1999 à 2017.
Źródło:
Medecine tropicale et sante internationale [Med Trop Sante Int] 2023 Oct 09; Vol. 3 (4). Date of Electronic Publication: 2023 Oct 09 (Print Publication: 2023).
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Leprostatic Agents*/therapeutic use
Leprosy*/drug therapy
Child ; Female ; Humans ; Adult ; Cote d'Ivoire/epidemiology ; Drug Therapy, Combination ; Hospitalization
Czasopismo naukowe
Tytuł:
[Analysis of national leprosy surveillance data in Mauritania from 2009 to 2019].
Autorzy:
Boushab BM; Médecine interne et maladies infectieuses, Centre hospitalier de Kiffa, Assaba, Mauritanie.; Programme national de lutte contre la tuberculose et la lèpre (PNTL), Nouakchott, Mauritanie.; Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
Yanogo PK; Faculté de médecine, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.; Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
Barry D; Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
Maham MH; Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.; Direction générale des Services de santé des Forces armées et de sécurité, Nouakchott, Mauritanie.
Traoré AMK; Programme national de lutte contre la tuberculose et la lèpre (PNTL), Nouakchott, Mauritanie.
Kane EM; Programme national de lutte contre la tuberculose et la lèpre (PNTL), Nouakchott, Mauritanie.
Basco L; Aix-Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France.; IHU-Méditerranée Infection, Marseille, France.
Meda N; Faculté de médecine, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.; Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
Pokaż więcej
Transliterated Title:
Analyse des données nationales de surveillance de la lèpre en Mauritanie de 2009 à 2019.
Źródło:
Medecine tropicale et sante internationale [Med Trop Sante Int] 2023 Apr 20; Vol. 3 (2). Date of Electronic Publication: 2023 Apr 20 (Print Publication: 2023).
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Leprostatic Agents*/therapeutic use
Leprosy*/epidemiology
Male ; Child ; Female ; Humans ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Retrospective Studies ; Mauritania/epidemiology ; Drug Therapy, Combination
Czasopismo naukowe
Tytuł:
Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells.
Autorzy:
Gao Q; School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
Huang C; School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
Liu T; School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
Yang F; Department of Laboratory Medicine, Lianyungang Clinical College of Jiangsu University, Lianyungang, Jiangsu, China.
Chen Z; Department of Gastrointestinal Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Sun L; Department of Clinical Laboratory, Affiliated Kunshan Hospital of Jiangsu University, Suzhou, Jiangsu, China.
Zhao Y; School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
Wang M; School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
Luo L; School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
Zhou C; Department of Laboratory Medicine, Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, China.
Zhu W; School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
Pokaż więcej
Źródło:
Journal of cellular biochemistry [J Cell Biochem] 2024 Mar; Vol. 125 (3), pp. e30521. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/genetics
Stomach Neoplasms*/pathology
Mesenchymal Stem Cells*/metabolism
Humans ; Drug Resistance, Neoplasm/genetics ; Tumor Necrosis Factor-alpha/metabolism ; Drug Therapy, Combination ; Leprostatic Agents/pharmacology ; Paclitaxel/pharmacology ; Paclitaxel/therapeutic use ; Oxaliplatin/pharmacology ; Oxaliplatin/therapeutic use ; Glycolysis ; Cell Line, Tumor ; Cell Proliferation
Czasopismo naukowe
Tytuł:
Effect of multidrug therapy on the prognosis of Mycobacterium avium complex pulmonary disease.
Autorzy:
Ushiki A; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. .
Tanaka S; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Yamanaka M; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Akahane J; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Ikuyama Y; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Komatsu M; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Sonehara K; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Ichiyama T; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Wada Y; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Tateishi K; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Kitaguchi Y; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Hanaoka M; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 23; Vol. 14 (1), pp. 4438. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium avium-intracellulare Infection*/microbiology
Lung Diseases*/microbiology
Humans ; Male ; Middle Aged ; Mycobacterium avium Complex ; Retrospective Studies ; Drug Therapy, Combination ; Leprostatic Agents/pharmacology ; Prognosis
Czasopismo naukowe
Tytuł:
Development of a multivariate predictive model for dapsone adverse drug events in people with leprosy under standard WHO multidrug therapy.
Autorzy:
de Araujo ACGDS; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (INI/Fiocruz), Rio de Janeiro, RJ, Brazil.
Hacker MAV; Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC/Fiocruz), Rio de Janeiro, RJ, Brazil.
Pinheiro RO; Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC/Fiocruz), Rio de Janeiro, RJ, Brazil.
Illarramendi X; Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC/Fiocruz), Rio de Janeiro, RJ, Brazil.
Durães SMB; Dermatology Department, Fluminense Federal University (UFF), Niterói, RJ, Brazil.
Nobre ML; Giselda Trigueiro Hospital, Rio Grande do Norte Federal State Public Health department (SESAP-RN), Natal, RN, Brazil.
Moraes MO; Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC/Fiocruz), Rio de Janeiro, RJ, Brazil.
Sales AM; Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC/Fiocruz), Rio de Janeiro, RJ, Brazil.
da Silva GMS; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (INI/Fiocruz), Rio de Janeiro, RJ, Brazil.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Jan 25; Vol. 18 (1), pp. e0011901. Date of Electronic Publication: 2024 Jan 25 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Leprosy*/drug therapy
Drug-Related Side Effects and Adverse Reactions*
Adult ; Humans ; Female ; Dapsone/adverse effects ; Leprostatic Agents/adverse effects ; Rifampin/therapeutic use ; Drug Therapy, Combination ; Case-Control Studies ; Clofazimine/therapeutic use ; Brazil/epidemiology ; World Health Organization
Czasopismo naukowe
Tytuł:
High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen.
Autorzy:
Chhabra S; Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector-12, Chandigarh, India. Electronic address: .
Narang T; Department of Dermatology, Venereology & Leprology, PGIMER, Sector-12, Chandigarh, India. Electronic address: .
Sahu S; Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector-12, Chandigarh, India.
Sharma K; Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector-12, Chandigarh, India.
Shilpa S; Department of Dermatology, Venereology & Leprology, PGIMER, Sector-12, Chandigarh, India.
Sharma A; Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector-12, Chandigarh, India.
Jain S; Department of Dermatology, Venereology & Leprology, PGIMER, Sector-12, Chandigarh, India.
Singh I; Stanley Browne Laboratory, The Leprosy Mission Community Hospital, Nand Nagari, New Delhi.
Yadav R; Department of Medical Microbiology, PGIMER, Sector-12, Chandigarh, India.
Kaur M; Department of Medical Microbiology, PGIMER, Sector-12, Chandigarh, India.
Sharma R; Stanley Browne Laboratory, The Leprosy Mission Community Hospital, Nand Nagari, New Delhi.
Nadeem M; Stanley Browne Laboratory, The Leprosy Mission Community Hospital, Nand Nagari, New Delhi.
Pandey P; Department of Dermatology, Venereology & Leprology, PGIMER, Sector-12, Chandigarh, India.
Minz RW; Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector-12, Chandigarh, India.
Dogra S; Department of Dermatology, Venereology & Leprology, PGIMER, Sector-12, Chandigarh, India. Electronic address: .
Pokaż więcej
Źródło:
Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2023 Dec; Vol. 35, pp. 262-267. Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium leprae*/genetics
Leprosy*/drug therapy
Leprosy*/epidemiology
Humans ; Rifampin/pharmacology ; Rifampin/therapeutic use ; Leprostatic Agents/pharmacology ; Leprostatic Agents/therapeutic use ; Ofloxacin/pharmacology ; Drug Therapy, Combination ; Cross-Sectional Studies ; Drug Resistance, Bacterial/genetics ; Dapsone/pharmacology ; Dapsone/therapeutic use ; India/epidemiology
Czasopismo naukowe
Tytuł:
Heterogeneous persistence of Mycobacterium leprae in oral and nasal mucosa of multibacillary patients during multidrug therapy.
Autorzy:
Neumann ADS; Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Microbiologia Celular, Rio de Janeiro, RJ, Brasil.; Universidade Federal do Rio de Janeiro, Instituto de Ciências Biomédicas, Laboratório de Investigação em Neuroprogramação, Rio de Janeiro, RJ, Brasil.
Fontes ANB; Ministério da Saúde, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Ciência e Tecnologia, Brasília, DF, Brasil.; Fundação Oswaldo Cruz-Fiocruz, Laboratório de Biologia Molecular Aplicada à Micobactérias, Rio de Janeiro, RJ, Brasil.
Lopes MQP; Fundação Oswaldo Cruz-Fiocruz, Laboratório de Biologia Molecular Aplicada à Micobactérias, Rio de Janeiro, RJ, Brasil.
Suffys PN; Fundação Oswaldo Cruz-Fiocruz, Laboratório de Biologia Molecular Aplicada à Micobactérias, Rio de Janeiro, RJ, Brasil.
Moraes MO; Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Hanseníase, Rio de Janeiro, RJ, Brasil.
Lara FA; Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Microbiologia Celular, Rio de Janeiro, RJ, Brasil.
Pokaż więcej
Źródło:
Memorias do Instituto Oswaldo Cruz [Mem Inst Oswaldo Cruz] 2022 Oct 17; Vol. 117, pp. e220058. Date of Electronic Publication: 2022 Oct 17 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium leprae*/genetics
Leprostatic Agents*/therapeutic use
Humans ; RNA, Ribosomal, 16S/genetics ; Drug Therapy, Combination ; Nasal Mucosa/microbiology ; DNA, Bacterial/genetics
Czasopismo naukowe
Tytuł:
An evidence and reasoning based differential diagnosis of a case of leprosy reinfection from reaction and relapse.
Autorzy:
Kumar V; Department of Experimental Animal Facility, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, Uttar Pradesh, 282004, India. Electronic address: .
Arora M; Clinical Division, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, Uttar Pradesh, 282004, India.
Gupta V; Department of Biochemistry, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, Uttar Pradesh, 282004, India.
Singh A; Department of Experimental Animal Facility, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, Uttar Pradesh, 282004, India.
Patil S; National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, Uttar Pradesh, 282004, India.
Pokaż więcej
Źródło:
Indian journal of medical microbiology [Indian J Med Microbiol] 2022 Oct-Dec; Vol. 40 (4), pp. 590-592. Date of Electronic Publication: 2022 Jul 09.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Leprostatic Agents*/therapeutic use
Leprosy*/diagnosis
Leprosy*/drug therapy
Leprosy*/microbiology
Diagnosis, Differential ; Drug Therapy, Combination ; Humans ; Mycobacterium leprae/genetics ; Recurrence ; Reinfection
Czasopismo naukowe
Tytuł:
Drug resistance in leprosy: An update following 70years of chemotherapy.
Autorzy:
Aubry A; Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses, U1135, AP-HP, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, 75013 Paris, France.
Sammarco Rosa P; Division of Research and Education, Instituto Lauro de Souza Lima, Bauru, São Paulo, Brazil.
Chauffour A; Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses, U1135, AP-HP, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, 75013 Paris, France.
Fletcher ML; Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA.
Cambau E; Université de Paris, INSERM, IAME, UMR 1137, AP-HP, GHU Nord, service de Mycobactériologie spécialisée et de référence, laboratoire associé au Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, 75018 Paris, France.
Avanzi C; Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA; Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland. Electronic address: .
Pokaż więcej
Źródło:
Infectious diseases now [Infect Dis Now] 2022 Aug; Vol. 52 (5), pp. 243-251. Date of Electronic Publication: 2022 Apr 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Leprostatic Agents*/pharmacology
Leprostatic Agents*/therapeutic use
Leprosy*/diagnosis
Leprosy*/drug therapy
Leprosy*/epidemiology
Drug Resistance ; Drug Therapy, Combination ; Humans ; Mycobacterium leprae/genetics
Czasopismo naukowe
Tytuł:
Sensitivity of different DNA extraction methods and PCR to detect resistance in patients with leprosy stratified by the bacilloscopic index.
Autorzy:
Sevilha-Santos L; Faculdade de Medicina, Programa de Pós-graduação em Ciências Médicas, Universidade de Brasília, Brasília, DF, Brazil.
Aquino DC; Faculdade de Medicina, Programa de Pós-graduação em Ciências Médicas, Universidade de Brasília, Brasília, DF, Brazil.
Hans Neto G; Universidade de Brasília, Hospital Universitário de Brasília, Brasília, DF, Brazil.
Costa FJQ; Laboratório Central de Saúde Pública do Distrito Federal, Secretaria de Saúde do Distrito Federal, Brasília, DF, Brazil.
de Sousa CAF; Laboratório Central de Saúde Pública do Distrito Federal, Secretaria de Saúde do Distrito Federal, Brasília, DF, Brazil.
Morelo EF; Faculdade de Medicina, Programa de Pós-graduação em Ciências Médicas, Universidade de Brasília, Brasília, DF, Brazil; Laboratório Central de Saúde Pública do Distrito Federal, Secretaria de Saúde do Distrito Federal, Brasília, DF, Brazil.
Santos Júnior ACMD; Laboratório Central de Saúde Pública do Distrito Federal, Secretaria de Saúde do Distrito Federal, Brasília, DF, Brazil.
Gomes CM; Faculdade de Medicina, Programa de Pós-graduação em Ciências Médicas, Universidade de Brasília, Brasília, DF, Brazil; Universidade de Brasília, Hospital Universitário de Brasília, Brasília, DF, Brazil; Núcleo de Medicina Tropical, Universidade de Brasília, Brasília, DF, Brazil. Electronic address: .
Pokaż więcej
Źródło:
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases [Braz J Infect Dis] 2022 Jul-Aug; Vol. 26 (4), pp. 102381. Date of Electronic Publication: 2022 Jun 27.
Typ publikacji:
Journal Article
MeSH Terms:
Leprostatic Agents*/pharmacology
Leprostatic Agents*/therapeutic use
Leprosy*/drug therapy
Bacterial Proteins/genetics ; DNA ; DNA, Bacterial/genetics ; Drug Resistance, Bacterial/genetics ; Humans ; Mycobacterium leprae/genetics ; Polymerase Chain Reaction/methods ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
MOF-Thermogel Composites for Differentiated and Sustained Dual Drug Delivery.
Autorzy:
Li X; Laboratory for Green Porous Materials, Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore 138634, Republic of Singapore.
Tan TTY; Laboratory for Green Porous Materials, Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore 138634, Republic of Singapore.
Lin Q; Laboratory for Green Porous Materials, Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore 138634, Republic of Singapore.
Lim CC; Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 1 Pesek Road Jurong Island, Singapore 627833, Republic of Singapore.
Goh R; Laboratory for Green Porous Materials, Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore 138634, Republic of Singapore.
Otake KI; Laboratory for Green Porous Materials, Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore 138634, Republic of Singapore.; Institute for Integrated Cell-Material Sciences, Kyoto University Institute for Advanced Study, Kyoto University, Yoshida Ushinomiya-cho, Sakyo-ku, Kyoto 606-8501, Japan.
Kitagawa S; Laboratory for Green Porous Materials, Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore 138634, Republic of Singapore.; Institute for Integrated Cell-Material Sciences, Kyoto University Institute for Advanced Study, Kyoto University, Yoshida Ushinomiya-cho, Sakyo-ku, Kyoto 606-8501, Japan.
Loh XJ; Laboratory for Green Porous Materials, Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore 138634, Republic of Singapore.; Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 1 Pesek Road Jurong Island, Singapore 627833, Republic of Singapore.; Department of Materials Science and Engineering, National University of Singapore (NUS), 9 Engineering Drive, Singapore 117576, Republic of Singapore.
Lim JYC; Laboratory for Green Porous Materials, Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore 138634, Republic of Singapore.; Department of Materials Science and Engineering, National University of Singapore (NUS), 9 Engineering Drive, Singapore 117576, Republic of Singapore.
Pokaż więcej
Źródło:
ACS biomaterials science & engineering [ACS Biomater Sci Eng] 2023 Oct 09; Vol. 9 (10), pp. 5724-5736. Date of Electronic Publication: 2023 Sep 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ibuprofen*
Caffeine*
Drug Therapy, Combination ; Leprostatic Agents
Czasopismo naukowe
Tytuł:
[Renal Side Effects of Novel Molecular Targeted Oncologic Agents].
Autorzy:
Fenoglio R; University Center of Excellence on Nephrological, Rheumatological and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Città di Torino and Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy.
Cortazzi S; University Center of Excellence on Nephrological, Rheumatological and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Città di Torino and Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy.
Marchisio M; University Center of Excellence on Nephrological, Rheumatological and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Città di Torino and Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy.
Rabajoli G; University Center of Excellence on Nephrological, Rheumatological and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Città di Torino and Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy.
Terzolo E; University Center of Excellence on Nephrological, Rheumatological and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Città di Torino and Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy.
Sciascia S; University Center of Excellence on Nephrological, Rheumatological and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Città di Torino and Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy.
Roccatello D; University Center of Excellence on Nephrological, Rheumatological and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Città di Torino and Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy.
Pokaż więcej
Źródło:
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia [G Ital Nefrol] 2023 Oct 03; Vol. 40 (Suppl 81). Date of Electronic Publication: 2023 Oct 03.
Typ publikacji:
English Abstract; Journal Article; Review
MeSH Terms:
Antineoplastic Agents*/adverse effects
Kidney Diseases*/drug therapy
Neoplasms*/drug therapy
Humans ; Drug Therapy, Combination ; Molecular Targeted Therapy/adverse effects ; Leprostatic Agents/adverse effects ; Kidney/pathology
Czasopismo naukowe
Tytuł:
Leprosy Relapse: A Retrospective Study on Epidemiologic, Clinical, and Therapeutic Aspects at a Brazilian Referral Center.
Autorzy:
Nascimento ACMD; Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil.
Dos Santos DF; National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil, Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil.
Antunes DE; National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil, Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil.
Gonçalves MA; National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil.
Santana MAO; National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil.
Dornelas BC; Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil; National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil, Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil.
Goulart LR; National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil, Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil, Institute of Genetics and Biochemistry, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil.
Goulart IMB; National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil, Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil. Electronic address: .
Pokaż więcej
Źródło:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2022 May; Vol. 118, pp. 44-51. Date of Electronic Publication: 2022 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Leprostatic Agents*/therapeutic use
Leprosy*/drug therapy
Brazil/epidemiology ; Chronic Disease ; Drug Therapy, Combination ; Humans ; Recurrence ; Referral and Consultation ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Comparison between lymecycline with multidrug therapy and standard multidrug regimen (WHO-MDT) in the treatment of multibacillary leprosy patients: a retrospective cohort study.
Autorzy:
Diaz JCD; Department of Dermatology, Jose R. Reyes Memorial Medical Center, Manila, Philippines.
Abad-Venida ML; Department of Dermatology, Jose R. Reyes Memorial Medical Center, Manila, Philippines.
Espinoza-Thaebtharm A; Department of Dermatology, Jose R. Reyes Memorial Medical Center, Manila, Philippines.
Cathryn Salonga ME; Department of Dermatology, Jose R. Reyes Memorial Medical Center, Manila, Philippines.
Abad-Casintahan MF; Department of Dermatology, Jose R. Reyes Memorial Medical Center, Manila, Philippines.
Pokaż więcej
Źródło:
International journal of dermatology [Int J Dermatol] 2023 Sep; Vol. 62 (9), pp. 1186-1192. Date of Electronic Publication: 2023 Jul 05.
Typ publikacji:
Journal Article
MeSH Terms:
Leprosy, Multibacillary*/drug therapy
Leprosy*/drug therapy
Humans ; Leprostatic Agents/therapeutic use ; Lymecycline/therapeutic use ; Drug Therapy, Combination ; Retrospective Studies ; World Health Organization
Czasopismo naukowe
Tytuł:
Recurrent choriocarcinoma complicated with leprosy during chemotherapy: A case report and literature review.
Autorzy:
Hu S; Department of Gynecology and Obstetrics, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, P. R. China.
Lin X; Department of Gynecology and Obstetrics, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, P. R. China.
Yin R; Department of Gynecology and Obstetrics, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, P. R. China.
Wang W; Department of Pathology, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, P. R. China.
Li Q; Department of Gynecology and Obstetrics, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, P. R. China.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2023 Aug 11; Vol. 102 (32), pp. e34548.
Typ publikacji:
Case Reports; Review; Journal Article
MeSH Terms:
Uterine Neoplasms*/pathology
Choriocarcinoma*/complications
Choriocarcinoma*/drug therapy
Choriocarcinoma*/diagnosis
Hydatidiform Mole*/diagnosis
Humans ; Pregnancy ; Female ; Young Adult ; Adult ; Drug Therapy, Combination ; Leprostatic Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Analysis of socioeconomic condition and bacillary index with respect to the development of Hansen's disease.
Autorzy:
Gautam S; Department of Biochemistry, ICMR-National Jalma Institute for Leprosy and Other Mycobacterial Diseases, Agra, Uttar Pradesh, India.
Sharma D; Department of Biochemistry, ICMR-National Jalma Institute for Leprosy and Other Mycobacterial Diseases, Agra, Uttar Pradesh, India.
Singh S; Clinical Division, ICMR-National Jalma Institute for Leprosy and Other Mycobacterial Diseases, Agra, Uttar Pradesh, India.
Arora M; Department of Biochemistry, ICMR-National Jalma Institute for Leprosy and Other Mycobacterial Diseases, Agra, Uttar Pradesh, India.
Goel A; Department of Biotechnology, GLA University, Mathura, Uttar Pradesh, India.
Bisht D; Department of Biochemistry, ICMR-National Jalma Institute for Leprosy and Other Mycobacterial Diseases, Agra, Uttar Pradesh, India.
Pokaż więcej
Źródło:
International journal of mycobacteriology [Int J Mycobacteriol] 2023 Jul-Sep; Vol. 12 (3), pp. 254-260.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Bacillus*
Leprosy*/diagnosis
Leprosy*/drug therapy
Leprosy*/epidemiology
Female ; Humans ; Male ; Drug Therapy, Combination ; Leprostatic Agents/therapeutic use ; Mycobacterium leprae ; Prospective Studies ; Socioeconomic Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies